Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauren P McLaughlin

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Allergy and Asthma Reports|January 25, 2017
Adoptive T Cell Immunotherapy for Patients with Primary Immunodeficiency DisordersLauren P McLaughlin, Catherine M Bollard, Michael Keller
Frontiers in Immunology|April 5, 2018
Adoptive T Cell Therapy for Epstein-Barr Virus Complications in Patients With Primary Immunodeficiency DisordersLauren P McLaughlin, Catherine M Bollard, Michael D Keller
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2016
EBV-Directed T Cell Therapeutics for EBV-Associated LymphomasLauren P McLaughlin, Stephen Gottschalk, Cliona M Rooney, et al.
Cytotherapy|October 4, 2016
Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytesLauren P McLaughlin, Haili Lang, Elizabeth Williams, et al.
Blood|September 29, 2018
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantationLauren P McLaughlin, Rayne Rouce, Stephen Gottschalk, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Allergy and Asthma Reports|January 25, 2017
Adoptive T Cell Immunotherapy for Patients with Primary Immunodeficiency DisordersLauren P McLaughlin, Catherine M Bollard, Michael Keller
Frontiers in Immunology|April 5, 2018
Adoptive T Cell Therapy for Epstein-Barr Virus Complications in Patients With Primary Immunodeficiency DisordersLauren P McLaughlin, Catherine M Bollard, Michael D Keller
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2016
EBV-Directed T Cell Therapeutics for EBV-Associated LymphomasLauren P McLaughlin, Stephen Gottschalk, Cliona M Rooney, et al.
Cytotherapy|October 4, 2016
Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytesLauren P McLaughlin, Haili Lang, Elizabeth Williams, et al.
Blood|September 29, 2018
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantationLauren P McLaughlin, Rayne Rouce, Stephen Gottschalk, et al.
Pageof 1